A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukaemia (AML) by helping ...

Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer ...

Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...

Cancer research in the U.S. doesn't rely on a single institution or funding stream − it's a complex ecosystem made up of ...

H. John Pounardjian has been named chief financial and administrative officer of Rutgers Cancer Institute in New Brunswick, N.J., effective June 1. Mr. Pounardjian will also serve as deputy director ...

A comprehensive colorectal cancer screening initiative in a large health system doubled colon cancer screening rates, ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...

Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain ...

The addition of neoadjuvant and adjuvant pembrolizumab to standard of care significantly improved outcomes for certain ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

A key House committee is being tasked with finding $880 billion of those cuts, most of which would likely come from Medicaid.

The cause of heart disease is generally clogged arteries. These blood vessels can be blocked by fatty plaque that contains ...